APOO and metabolic syndrome: Furthermore, plasma proprotein convertase subtilisin/kexin type 9 (PCSK9), which also participates in dyslipidemia in obesity [18], were comparable between Apoo+/+ and Apoo−/− mice (Supplementary Fig. 2E).